(Q30760776)

26 June 2017

Protection of rhesus macaques against disease progression from pathogenic SHIV-89.6PD by vaccination with phage-displayed HIV-1 epitopes (English)

1 reference

26 June 2017

14

A S Fauci

1 reference

26 June 2017

X Chen

1

1 reference

26 June 2017

G Scala

2

1 reference

26 June 2017

I Quinto

3

1 reference

26 June 2017

W Liu

4

1 reference

26 June 2017

T W Chun

5

1 reference

26 June 2017

J S Justement

6

1 reference

26 June 2017

O J Cohen

7

1 reference

26 June 2017

T C vanCott

8

1 reference

26 June 2017

M Iwanicki

9

1 reference

26 June 2017

M G Lewis

10

1 reference

26 June 2017

J Greenhouse

11

1 reference

26 June 2017

T Barry

12

1 reference

26 June 2017

D Venzon

13

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 November 2001

1 reference

26 June 2017

1 reference

26 June 2017

7

1 reference

26 June 2017

1225-1231

1 reference

26 June 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nm1101-1225

26 June 2017

0 references

cites work

Prevention of HIV-1 infection in chimpanzees by gpl20 V3 domain-specific monoclonal antibody

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Neutralizing antibody directed against the HIV-1 envelope glycoprotein can completely block HIV-1/SIV chimeric virus infections of macaque monkeys.

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Antibodies and resistance to natural HIV infection

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Identification of a new human immunodeficiency virus type 1 distinct from group M and group O.

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Evaluation of immune responses induced by HIV-1 gp120 in rhesus macaques: effect of vaccination on challenge with pathogenic strains of homologous and heterologous simian human immunodeficiency viruses

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Selection of biologically active peptides by phage display of random peptide libraries

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Induction of anti-carbohydrate antibodies by phage library-selected peptide mimics

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

A role for carbohydrates in immune evasion in AIDS.

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Multiple display of foreign peptides on a filamentous bacteriophage. Peptides from Plasmodium falciparum circumsporozoite protein as antigens.

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Structural mimicry and enhanced immunogenicity of peptide epitopes displayed on filamentous bacteriophage. The V3 loop of HIV-1 gp120

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Evaluation of CD4+ T cell function In vivo in HIV-infected patients as measured by bacteriophage phiX174 immunization.

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Evidence for coinfection by multiple strains of human immunodeficiency virus type 1 subtype B in an acute seroconvertor.

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

HIV-1 heterogeneity and cytokines. Neuropathogenesis.

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

The antigenic structure of the HIV gp120 envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Genomic cloning and complete sequence analysis of a highly divergent African human immunodeficiency virus isolate

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

A human monoclonal antibody to HIV-1 gp41 with neutralizing activity against diverse laboratory isolates

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Immunotyping of human immunodeficiency virus type 1 (HIV): an approach to immunologic classification of HIV

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Characterization of molecularly cloned simian-human immunodeficiency viruses causing rapid CD4+ lymphocyte depletion in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Plasma SIV RNA viral load determination by real-time quantification of product generation in reverse transcriptase-polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Polyvalent envelope glycoprotein vaccine elicits a broader neutralizing antibody response but is unable to provide sterilizing protection against heterologous Simian/human immunodeficiency virus infection in pigtailed macaques

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Neutralizing antibodies from the sera of human immunodeficiency virus type 1-infected individuals bind to monomeric gp120 and oligomeric gp140

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Vaccine-elicited V3 loop-specific antibodies in rhesus monkeys and control of a simian-human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate envelope

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

HIV type 1 subtypes in Malaysia, determined with serologic assays: 1992-1996

1 reference

https://api.crossref.org/works/10.1038%2FNM1101-1225

7 January 2021

Identifiers

DOI

10.1038/NM1101-1225

1 reference

26 June 2017

1 reference